MedPath

TD Vaccines A/S

🇩🇰Denmark
Ownership
Private
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:0
Completed:2

Trial Phases

2 Phases

Phase 1:1
Phase 2:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials

Phase 2
2 (66.7%)
Phase 1
1 (33.3%)

Safety and Efficacy Study of a Vaccine Against Enterotoxigenic Escherichia Coli (ETEC) to Prevent Moderate to Severe Diarrhea

Phase 2
Completed
Conditions
Diarrhea
First Posted Date
2010-02-02
Last Posted Date
2011-03-07
Lead Sponsor
TD Vaccines A/S
Target Recruit Count
70
Registration Number
NCT01060748
Locations
🇺🇸

Center for Immunization Research (CIR), Baltimore, Maryland, United States

ACE527 Safety and Immunogenicity Study

Phase 1
Completed
Conditions
Enterotoxigenic E. Coli (ETEC) Infection
First Posted Date
2009-05-14
Last Posted Date
2010-01-29
Lead Sponsor
TD Vaccines A/S
Target Recruit Count
36
Registration Number
NCT00901654
Locations
🇺🇸

Center for Immunization Research CIR, Baltimore, Maryland, United States

ACE393-103 Vaccination Challenge Study

Phase 2
Conditions
Campylobacter Infection
First Posted Date
2009-03-11
Last Posted Date
2009-03-11
Lead Sponsor
TD Vaccines A/S
Target Recruit Count
72
Registration Number
NCT00859716
Locations
🇺🇸

Shin Nippon Biomedical Laboratories, Baltimore, Maryland, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.